BSE filing, BSE: 531686. Summary written from the filing by ALFA Finder's alert engine.
Advik Laboratories Ltd: key numbers
- Share price
- ₹2.08
- Market cap
- ₹3.98 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.02 Cr
- P/E (TTM)
- -3.8×Sector 46.1×
- Promoter holding
- 35.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advik Laboratories Ltd
All →Advik Laboratories Other Announcement
MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.
MPS Pharma Management Change
MPS Pharmaa Limited announced the appointment of Anchal Goyal as an Independent Director for a five-year term. The company also re-appointed Ram Niwas Sharma and statutory auditors Nemani Garg Agarwal & Co.
Advik Laboratories Annual General Meeting
MPS Pharmaa Limited held its 32nd Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of audited financial statements and director appointments.
Advik Laboratories Other Announcement
MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.
Advik Laboratories Annual General Meeting
The company submitted its 32nd Annual Report and AGM notice for FY 2025-26. The meeting is scheduled for September 29, 2026.
Advik Laboratories Board Meeting Date
MPS Pharmaa Limited has scheduled a board meeting on September 02, 2026, to consider the notice for the company's upcoming Annual General Meeting.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.